Sanyal AJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002, 123: 1705-25. 10.1053/gast.2002.36572.
Article
PubMed
Google Scholar
Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346: 1221-31. 10.1056/NEJMra011775.
Article
CAS
PubMed
Google Scholar
Charlton M: Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004, 2: 1048-58. 10.1016/S1542-3565(04)00440-9.
Article
PubMed
Google Scholar
Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002, 123: 134-140. 10.1053/gast.2002.34168.
Article
PubMed
Google Scholar
Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, Giral P, Grimaldi A, Opolon P, Poynard T: Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002, 35: 1485-93. 10.1053/jhep.2002.33324.
Article
PubMed
Google Scholar
Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T: Liver fibrosis in overweight patients. Gastroenterology. 2000, 118: 1117-1123. 10.1016/S0016-5085(00)70364-7.
Article
CAS
PubMed
Google Scholar
Talwalkar JA: Motion – all patients with NASH need to have a liver biopsy: arguments for the motion. Can J Gastroenterol. 2002, 16: 718-21.
Article
PubMed
Google Scholar
Laurin J: Motion – all patients with NASH need to have a liver biopsy: arguments against the motion. Can J Gastroenterol. 2002, 16: 722-6.
Article
PubMed
Google Scholar
McGill DB, Rakela J, Zinsmeister AR, Ott BJ: A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990, 99: 1396-400.
CAS
PubMed
Google Scholar
Cadranel JF, Rufat P, Degos F: Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000, 32: 477-81. 10.1053/jhep.2000.16602.
Article
CAS
PubMed
Google Scholar
Poynard T, Ratziu V, Bedossa P: Appropriateness of liver biopsy. Can J Gastroenterol. 2000, 14: 543-8.
Article
CAS
PubMed
Google Scholar
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, for the LIDO Study Group: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005, 128: 1898-1906. 10.1053/j.gastro.2005.03.084.
Article
PubMed
Google Scholar
Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, Rybicki L, McCullough AJ: Non-alcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol. 1998, 11: 560-565.
CAS
PubMed
Google Scholar
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ: Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005, 41: 1313-21. 10.1002/hep.20701.
Article
PubMed
Google Scholar
Bellentani S, Bedogni G, Miglioli L, Tiribelli C: The epidemiology of fatty liver. Eur J Gastroenterol Hepatol. 2004, 16: 1087-93. 10.1097/00042737-200411000-00002.
Article
PubMed
Google Scholar
Sorbi D, Boynton J, Lindor KD: The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999, 94: 1018-1022. 10.1111/j.1572-0241.1999.01006.x.
Article
CAS
PubMed
Google Scholar
Dixon JB, Bhathal PS, O'Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001, 121: 91-100. 10.1053/gast.2001.25540.
Article
CAS
PubMed
Google Scholar
Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM: Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg. 2005, 15: 310-5. 10.1381/0960892053576820.
Article
PubMed
Google Scholar
Boza C, Riquelme A, Ibanez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M: Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005, 15: 1148-53. 10.1381/0960892055002347.
Article
PubMed
Google Scholar
Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Loberg E, Haaland T, Birkeland K, Bjoro K: Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol. 2005, 40: 1469-77. 10.1080/00365520500264953.
Article
CAS
PubMed
Google Scholar
Park KS, Lee YS, Park HW, Seo SH, Jang BG, Hwang JY, Cho KB, Hwang JS, Ahn SH, Kang YN, Kim GC: Factors associated or related to with pathological severity of non-alcoholic fatty liver disease. Korean J Intern Med. 2004, 19: 19-26.
Article
PubMed
PubMed Central
Google Scholar
Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, Shiroma J, Toyama A, Nakayoshi T, Kinjo F, Saito A: Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2005, 11: 255-9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, Seckin D, Sahin K: Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology. 2005, 52: 1549-53.
CAS
PubMed
Google Scholar
Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M: Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Turk J Gastroenterol. 2003, 14: 12-7.
PubMed
Google Scholar
Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, Victor de Ledinghen V, Poynard T, for the LIDO Study Group and the CYTOL study group: Diagnostic Value of Biochemical Markers (FibroTest-FibroSURE) for the prediction of Liver Fibrosis in patients with Non-Alcoholic Fatty Liver Disease. BMC Gastroenterology. 2006, 6: 6-10.1186/1471-230X-6-6.
Article
PubMed
PubMed Central
Google Scholar
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001, 357: 1069-75. 10.1016/S0140-6736(00)04258-6.
Article
CAS
PubMed
Google Scholar
Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, Thibault V, Benhamou Y, Moussalli J, Ratziu V: Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C. Clin Chem. 2004, 50: 1344-55. 10.1373/clinchem.2004.032227.
Article
CAS
PubMed
Google Scholar
Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B: Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol. 2004, 3: 8-10.1186/1476-5926-3-8.
Article
PubMed
PubMed Central
Google Scholar
Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T: Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol. 2003, 39: 222-30. 10.1016/S0168-8278(03)00171-5.
Article
CAS
PubMed
Google Scholar
Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, Deny P, Landais P, El HasnaouiP A, Slama A, Blin P, Thibault D, Parvaz P, Munteanu M, Trepo C: Longitudinal assessment of histology surrogate markers (Fibrotest-Actitest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gast. 2005, 100: 1970-80. 10.1111/j.1572-0241.2005.41957.x.
Article
CAS
Google Scholar
Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T: Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol. 2005, 3: 167-74. 10.1016/S1542-3565(04)00625-1.
Article
PubMed
Google Scholar
Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R: Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004, 10: 429-34. 10.1038/nm1006.
Article
CAS
PubMed
Google Scholar
Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V: Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005, 128: 343-50. 10.1053/j.gastro.2004.11.018.
Article
PubMed
Google Scholar
Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C, Chevailler A, Lunel F: A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005, 42: 1373-81. 10.1002/hep.20935.
Article
PubMed
Google Scholar
Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J: The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol. 2005, 4: 10-10.1186/1476-5926-4-10.
Article
PubMed
PubMed Central
Google Scholar
Thabut D, Naveau S, Frederic Charlotte F, Massard J, Ratziu V, Imbert-Bismut F, Cazals-Hatem D, Abella A, Messous D, Beuzen F, Munteanu M, Taieb J, Moreau R, Lebrec D, Poynard T: The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato hepatitis in patients with chronic alcoholic liver disease. J Hepatol. 2006, 52: 1887-96.
Google Scholar
DeLong ER, DeLong DM, Clarkelus DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44: 837-45. 10.2307/2531595.
Article
CAS
PubMed
Google Scholar
Zhou X, Obuchowski N, McClish D: In: Statistical Methods in Diagnostic Medicine. 2002, John Wiley & Sons I, ed. New York New York
Chapter
Google Scholar
Rockey DC, Bissell DM: Noninvasive measures of liver fibrosis. Hepatology. 2006, 43: S113-20. 10.1002/hep.21046.
Article
CAS
PubMed
Google Scholar
Barrett AJ, Starkey PM: The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J. 1973, 133: 709-24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gray RS, James K, Merriman J, Starkey IR, Elton RA, Clarke BF, Duncan LJ: Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes. Horm Metab Res. 1982, 14: 389-92.
Article
CAS
PubMed
Google Scholar
Chu CT, Rubenstein DS, Enghild JJ, Pizzo SV: Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding. Biochemistry. 1991, 30: 1551-60. 10.1021/bi00220a016.
Article
CAS
PubMed
Google Scholar
Westwood M, Aplin JD, Collinge IA, Gill A, White A, Gibson JM: alpha 2-macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protien-1 axis. J Biol Chem. 2001, 276: 41668-74. 10.1074/jbc.M102793200.
Article
CAS
PubMed
Google Scholar
Bedossa P, Dargère D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003, 38: 1449-57.
Article
PubMed
Google Scholar
Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology. 2003, 37: 1202-1219. 10.1053/jhep.2003.50193.
Article
PubMed
Google Scholar
Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ: Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003, 37: 1286-92. 10.1053/jhep.2003.50229.
Article
PubMed
Google Scholar
Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, Gennarelli N, Lobello R: Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol. 2004, 41: 751-7. 10.1016/j.jhep.2004.07.010.
Article
CAS
PubMed
Google Scholar
Kunde SS, Lazenby AJ, Clements RH, Abrams GA: Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology. 2005, 42: 650-6. 10.1002/hep.20818.
Article
PubMed
Google Scholar
Poynard T, Ratziu V, Benhamou Y, Thabut D, Moussalli J: Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?. Gastroenterology. 2005, 128: 1146-8. 10.1053/j.gastro.2005.02.056. author reply 1148
Article
PubMed
Google Scholar